Trial intelligence / Profile preview

Quetiapine in Anorexia Nervosa

NCT00584688Phase 2Terminated

Sponsor
University of South Florida
Start
Feb 2007
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of quetiapine in anorexia nervosa (AN), sponsored by University of South Florida. Primary endpoint: Efficacy of Seroquel in anorexia nervosa at 8 weeks. Started Feb 2007; status: terminated.

02

Drugs

quetiapine
03

Conditions

anorexia nervosa (AN)

Beyond the preview

Go deeper on NCT00584688.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00584688.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call